Compass Carter Osborne (CCO) have announced that Abigail Badá has been appointed as director to the firm’s people and culture practice.
In other news...Harris Williams: Dr Julian Feneley
Harris Williams, a global investment bank focused on M&A advisory services, has appointed Dr Julian Feneley as managing director, Healthcare & Life Sciences (HCLS) in the firm’s London office.
Feneley has almost 30 years of healthcare and life sciences industry experience and will lead HCLS’s European efforts across its key verticals, including pharma services, medical devices, and numerous healthcare provider segments.
Feneley was previously managing director and head of healthcare Europe at Macquarie Capital (the investment banking division of Macquarie Group). His previous experience includes head of healthcare investment banking Europe at Canaccord Genuity, after leading healthcare investment banking in Europe at JP Morgan. He was also chief executive of BriteSmile, a US dental technology company with 7,000 dental practice clients worldwide.
In a statement Bob Baltimore and John Neuner, co-heads of M&A at Harris Williams said: “As a seasoned and trusted advisor and proven industry executive, Julian brings an extensive understanding of the healthcare landscape and universe of sponsors and corporates globally that is critical to navigating an increasingly active and dynamic sector. Moreover, Julian values our firm’s culture of collaboration and integrity, and we look forward to his many contributions as we further strengthen our ability to meet increasing client demand across Europe.”
Feneley added: “Harris Williams has an outstanding reputation of unlocking value for its clients, and I’m delighted to join its insightful and dedicated team at this exciting time in the firm’s growth. I look forward to collaborating with my new colleagues as the firm continues to build its global presence.”
Cheairs Porter and Geoff Smith, co-heads of Harris Williams’ Healthcare & Life Sciences Group, commented: “The sustained, robust expansion of healthcare and life sciences globally demands the deep industry relationships, expertise, and execution capabilities that Julian brings to our growing European business. We believe our unrivalled sector knowledge and unwavering commitment to client service uniquely positions us to guide our corporate and financial sponsor clients as they seek to capitalise on attractive opportunities around the world.”
Latest Executive Moves
Reframe Cancer has appointed Professor Ben Kelly as chief operating officer.
In other news...Amélie Chollet has been appointed partner in CMS’ life sciences and healthcare group in London.
In other news...